logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Macgregor, Barbara
    Project Manager born in March 1972
    Individual (3 offsprings)
    Officer
    2013-10-16 ~ now
    OF - Director → CIF 0
    Mrs Barbara Macgregor
    Born in March 1972
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
  • 2
    David Ronald Taylor
    Individual (472 offsprings)
    Insolvency
    2024-07-30 ~ now
    IP - (Case 1) practitioner → CIF 0
  • 3
    Paul Ellison
    Individual (840 offsprings)
    Insolvency
    2024-07-30 ~ now
    IP - (Case 1) practitioner → CIF 0
parent relation
Company in focus

MACGREGOR PHARMA CONSULTING LIMITED

Period: 2017-11-20 ~ 2025-02-11
Company number: 08735567
Registered names
MACGREGOR PHARMA CONSULTING LIMITED - Dissolved
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Average Number of Employees
12022-04-01 ~ 2023-03-31
12021-04-01 ~ 2022-03-31
Property, Plant & Equipment
4,454 GBP2023-03-31
7,164 GBP2022-03-31
Fixed Assets
4,454 GBP2023-03-31
7,164 GBP2022-03-31
Debtors
Current
8,381 GBP2023-03-31
2 GBP2022-03-31
Cash at bank and in hand
133,238 GBP2023-03-31
182,665 GBP2022-03-31
Current Assets
141,619 GBP2023-03-31
182,667 GBP2022-03-31
Net Current Assets/Liabilities
132,633 GBP2023-03-31
168,349 GBP2022-03-31
Total Assets Less Current Liabilities
137,087 GBP2023-03-31
175,513 GBP2022-03-31
Net Assets/Liabilities
135,973 GBP2023-03-31
173,642 GBP2022-03-31
Equity
Called up share capital
100 GBP2023-03-31
100 GBP2022-03-31
Retained earnings (accumulated losses)
135,873 GBP2023-03-31
173,542 GBP2022-03-31
Equity
135,973 GBP2023-03-31
173,642 GBP2022-03-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
8,078 GBP2023-03-31
7,839 GBP2022-03-31
Office equipment
9,825 GBP2023-03-31
9,685 GBP2022-03-31
Property, Plant & Equipment - Gross Cost
17,903 GBP2023-03-31
17,524 GBP2022-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
4,104 GBP2022-03-31
Office equipment
6,256 GBP2022-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
10,360 GBP2022-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
1,806 GBP2022-04-01 ~ 2023-03-31
Owned/Freehold
3,089 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
5,387 GBP2023-03-31
Office equipment
8,062 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
13,449 GBP2023-03-31
Property, Plant & Equipment
Furniture and fittings
2,691 GBP2023-03-31
3,735 GBP2022-03-31
Office equipment
1,763 GBP2023-03-31
3,429 GBP2022-03-31
Trade Debtors/Trade Receivables
Current
2 GBP2022-03-31
Amount of corporation tax that is recoverable
Current
8,381 GBP2023-03-31
Corporation Tax Payable
Current
10,599 GBP2022-03-31
Taxation/Social Security Payable
Current
23 GBP2022-03-31
Other Creditors
Current
6,486 GBP2023-03-31
1,196 GBP2022-03-31
Accrued Liabilities/Deferred Income
Current
2,500 GBP2023-03-31
2,500 GBP2022-03-31
Creditors
Current
8,986 GBP2023-03-31
14,318 GBP2022-03-31
Net Deferred Tax Liability/Asset
-1,114 GBP2023-03-31
-1,871 GBP2022-03-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
757 GBP2022-04-01 ~ 2023-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
-1,114 GBP2023-03-31
-1,871 GBP2022-03-31

  • MACGREGOR PHARMA CONSULTING LIMITED
    Info
    MACGREGOR PHARMA CONSULTANCY LIMITED - 2017-11-20
    BARBARA MACGREGOR LIMITED - 2017-11-20
    Registered number 08735567
    C/o Kre Corporate Recovery Limited, Unit 8, The Aquarium, 1-7 King Street, Reading RG1 2AN
    PRIVATE LIMITED COMPANY incorporated on 2013-10-16 and dissolved on 2025-02-11 (11 years 3 months). The status of the company number is Dissolved.
    The last date of confirmation statement was made at 2023-10-16
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.